{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06223828",
            "orgStudyIdInfo": {
                "id": "CR-AZI"
            },
            "secondaryIdInfos": [
                {
                    "id": "IRB00410054",
                    "type": "OTHER",
                    "domain": "Johns Hopkins University"
                }
            ],
            "organization": {
                "fullName": "Johns Hopkins All Children's Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Azithromycin for Critical Asthma - Pediatrics",
            "officialTitle": "Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking",
            "acronym": "CR-AZI Kids",
            "therapeuticArea": [
                "Critical Care",
                "Respiratory"
            ],
            "study": "azithromycin-for-critical-asthma-pediatrics"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-16",
            "studyFirstSubmitQcDate": "2024-01-16",
            "studyFirstPostDateStruct": {
                "date": "2024-01-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Johns Hopkins All Children's Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.",
            "detailedDescription": "Azithromycin (AZI), a macrolide antibiotic, has been applied for adult and pediatric respiratory pathology to alter immune system response.1 For pediatric critical asthma (CA), a term used to describe a critically ill child hospitalized with an asthma exacerbation requiring an intensive care unit (PICU) hospitalization, the investigator's prior research has revealed 1 in 10 will receive AZI.2 Yet, the application of AZI in this setting is poorly studied nor is clear if, and to what degree AZI alters the immune response in conjunction with systemic corticosteroids traditionally applied in CA.\n\nIn this proposal, the investigators aim to characterize a respiratory epithelial inflammatory biomarker, periostin, among children with CA with and without exposure to AZI. The investigators hypothesize children receiving AZI will have lower periostin levels. As a secondary analysis, the investigators will describe the rates of adverse events related to AZI (previously not done) and explore differences in clinical and physiologic CA efficacy markers."
        },
        "conditionsModule": {
            "conditions": [
                "Pediatric Asthma",
                "Critical Illness"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Children will be enrolled into either a single interventional arm or a parallel standard care arm.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Azithromycin Intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this arm will receive Azithromycin 10mg/kg/dose (max dose 500mg) once daily for 3 days.",
                    "interventionNames": [
                        "Drug: Azithromycin"
                    ]
                },
                {
                    "label": "Standard Care",
                    "type": "NO_INTERVENTION",
                    "description": "Participants will receive standard care without Azithromycin."
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Azithromycin",
                    "description": "10mg/kg/dose (max dose 500mg) once daily for 3 days",
                    "armGroupLabels": [
                        "Azithromycin Intervention"
                    ],
                    "otherNames": [
                        "Zithromax"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Plasma Periostin Levels and Degree of Change (e.g., Slope) - Primary Physiologic Efficacy Endpoint",
                    "description": "ng/dL",
                    "timeFrame": "24 hours, 48 hours, and 72-hours following enrollment"
                },
                {
                    "measure": "Drug-related adverse event rate (Primary Safety Endpoint)",
                    "description": "cumulative incidence rate",
                    "timeFrame": "During hospitalization, approximately 3 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Length of Stay (Secondary Clinical Efficacy Endpoint)",
                    "description": "Measured in Days, from Hospitalization in ICU through Discharge from ICU",
                    "timeFrame": "During hospitalization, approximately 3 days"
                },
                {
                    "measure": "Duration of continuous albuterol (Secondary Clinical Efficacy Endpoint)",
                    "description": "Measured in Hours from ICU hospitalization through discharge",
                    "timeFrame": "During hospitalization, approximately 3 days"
                },
                {
                    "measure": "Composite use of adjunct asthma treatments (Secondary Clinical Efficacy Endpoint)",
                    "description": "Cumulative Frequency of Exposure, from ICU Hospitalization through ICU discharge",
                    "timeFrame": "During hospitalization, approximately 3 days"
                },
                {
                    "measure": "Transcutaneous carbon dioxide levels (Secondary physiologic efficacy Endpoint)",
                    "description": "Measured in mmHg of Carbon Dioxide, peak values measured daily at each study visit",
                    "timeFrame": "Enrollment, Day 1, Day 2, Day 3, at ICU Discharge"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria\n\n* Age 3-17 years\n* Admission to the PICU\n* Primary diagnosis of critical asthma\n* Prescription for continuous inhaled beta-agonist therapy and/or intravenous (IV) beta-agonist therapy\n* Prescription for intravenous systemic corticosteroids\n\nExclusion criteria\n\n* Critical Congenital Heart Disease Unrepaired\n* Tracheostomy Dependence at Admission\n* Ongoing Exposure to Azithromycin or Macrolide Antibiotics for any indication\n* Past Medical History of Prolonged QT Syndrome or Arrhythmias\n* Concomitant respiratory pathology including Acute Chest Syndrome, Interstitial Lung Disease, Cystic Fibrosis, and pulmonary hypertension",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Anthony A Sochet, MD",
                    "role": "CONTACT",
                    "phone": "727-487-3711",
                    "email": "Sochet@jhmi.edu"
                },
                {
                    "name": "Alexa R Roberts, MD",
                    "role": "CONTACT",
                    "phone": "602-526-4397",
                    "email": "arober77@jhmi.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Anthony A Sochet, MD",
                    "affiliation": "Johns Hopkins All Children's Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Johns Hopkins All Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "state": "Florida",
                    "zip": "33701",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anthony A Sochet, MD",
                            "role": "CONTACT",
                            "phone": "727-767-2912",
                            "email": "sochet@jhmi.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.77086,
                        "lon": -82.67927
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "No plan to share with other researchers."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001249",
                    "term": "Asthma"
                },
                {
                    "id": "D000016638",
                    "term": "Critical Illness"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001982",
                    "term": "Bronchial Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000008173",
                    "term": "Lung Diseases, Obstructive"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012130",
                    "term": "Respiratory Hypersensitivity"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4556",
                    "name": "Asthma",
                    "asFound": "Asthma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19010",
                    "name": "Critical Illness",
                    "asFound": "Critical Illness",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5258",
                    "name": "Bronchial Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11170",
                    "name": "Lung Diseases, Obstructive",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M14967",
                    "name": "Respiratory Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017963",
                    "term": "Azithromycin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20132",
                    "name": "Azithromycin",
                    "asFound": "Fasting",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}